LeonaBio (LONA) Operating Expenses (2019 - 2026)

LeonaBio (LONA) has 8 years of Operating Expenses data on file, last reported at $893000.0 in Q1 2026.

• Quarterly Operating Expenses fell 52.5% year-over-year to $893000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.7 million (down 29.26% YoY) and the FY2025 annual result came in at $102.3 million, up 1.35% from the prior year.
• Operating Expenses fell to $893000.0 in Q1 2026 per LONA's latest filing, from $96.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at $96.9 million in Q4 2025 and bottomed at $893000.0 in Q1 2026.
• The 5-year median for Operating Expenses is $28.0 million (2024), against an average of $28.8 million.
• The widest annual swing landed in 2024, when Operating Expenses surged 214.87%; it then sank 94.42% in 2025.
• Tracing LONA's Operating Expenses over 5 years: stood at $32.9 million in 2022, then dropped by 11.88% to $29.0 million in 2023, then surged by 214.87% to $91.4 million in 2024, then increased by 6.06% to $96.9 million in 2025, then slumped by 99.08% to $893000.0 in 2026.
• Per Business Quant, the three latest LONA Operating Expenses figures stand at $893000.0 (Q1 2026), $96.9 million (Q4 2025), and $1.7 million (Q3 2025).

Peer Comparison